192 related articles for article (PubMed ID: 22115926)
1. Survival in cancer of unknown primary site: population-based analysis by site and histology.
Hemminki K; Bevier M; Hemminki A; Sundquist J
Ann Oncol; 2012 Jul; 23(7):1854-63. PubMed ID: 22115926
[TBL] [Abstract][Full Text] [Related]
2. Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.
Kim CS; Hannouf MB; Sarma S; Rodrigues GB; Rogan PK; Mahmud SM; Winquist E; Brackstone M; Zaric GS
Acta Oncol; 2015 Nov; 54(10):1781-7. PubMed ID: 25825957
[TBL] [Abstract][Full Text] [Related]
3. Site-specific survival rates for cancer of unknown primary according to location of metastases.
Hemminki K; Riihimäki M; Sundquist K; Hemminki A
Int J Cancer; 2013 Jul; 133(1):182-9. PubMed ID: 23233409
[TBL] [Abstract][Full Text] [Related]
4. Site-specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primaries.
Hemminki K; Bevier M; Sundquist J; Hemminki A
Int J Cancer; 2013 Feb; 132(4):944-50. PubMed ID: 22730111
[TBL] [Abstract][Full Text] [Related]
5. Time trends in survival from cancer of unknown primary: small steps forward.
Riihimäki M; Hemminki A; Sundquist K; Hemminki K
Eur J Cancer; 2013 Jul; 49(10):2403-10. PubMed ID: 23518210
[TBL] [Abstract][Full Text] [Related]
6. A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network.
Shaw PH; Adams R; Jordan C; Crosby TD
Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):87-95. PubMed ID: 17305260
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of prognostic factors in 68 patients with cancer of unknown primary site].
Kou XG; Liang DL; Zhang QQ; Li XR; Zhao YZ; Gu JF; Lu P
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):783-6. PubMed ID: 22335913
[TBL] [Abstract][Full Text] [Related]
9. Melanoma of unknown primary origin: a population-based study in the Netherlands.
de Waal AC; Aben KK; van Rossum MM; Kiemeney LA
Eur J Cancer; 2013 Feb; 49(3):676-83. PubMed ID: 23031553
[TBL] [Abstract][Full Text] [Related]
10. Liver metastases from adenocarcinomas of unknown primary site: management and prognosis in 68 consecutive patients.
Algin E; Ozet A; Gumusay O; Yilmaz G; Buyukberber S; Coskun U; Baykara M; Cetin B; Yıldız R; Benekli M
Wien Klin Wochenschr; 2016 Jan; 128(1-2):42-7. PubMed ID: 26373751
[TBL] [Abstract][Full Text] [Related]
11. The role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the management of patients with carcinoma of unknown primary.
Deonarine P; Han S; Poon FW; de Wet C
Scott Med J; 2013 Aug; 58(3):154-62. PubMed ID: 23960054
[TBL] [Abstract][Full Text] [Related]
12. Cancer of unknown primary site: review of consecutive cases at the National Cancer Center Hospital of Japan.
Yakushiji S; Ando M; Yonemori K; Kohno T; Shimizu C; Katsumata N; Fujiwara Y
Int J Clin Oncol; 2006 Dec; 11(6):421-5. PubMed ID: 17180509
[TBL] [Abstract][Full Text] [Related]
13. Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma.
Lee CC; Faries MB; Wanek LA; Morton DL
J Clin Oncol; 2008 Feb; 26(4):535-41. PubMed ID: 18235114
[TBL] [Abstract][Full Text] [Related]
14. Chemoradiation as a definitive treatment for cervical lymph node metastases from unknown primary cancer.
Kaizu H; Ogino I; Hata M; Oba MS; Shiono O; Komatsu M; Inoue T
Anticancer Res; 2013 Nov; 33(11):5187-92. PubMed ID: 24222168
[TBL] [Abstract][Full Text] [Related]
15. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
16. Cervical lymph node metastases from occult squamous cell carcinoma: analysis of 82 cases.
Boscolo-Rizzo P; Da Mosto MC; Gava A; Marchiori C
ORL J Otorhinolaryngol Relat Spec; 2006; 68(4):189-94. PubMed ID: 16479145
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in 1,521 melanoma patients with distant metastases.
Barth A; Wanek LA; Morton DL
J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
[TBL] [Abstract][Full Text] [Related]
18. Lymph node metastases in the lower neck.
Giridharan W; Hughes J; Fenton JE; Jones AS
Clin Otolaryngol Allied Sci; 2003 Jun; 28(3):221-6. PubMed ID: 12755760
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis.
Coit DG; Rogatko A; Brennan MF
Ann Surg; 1991 Nov; 214(5):627-36. PubMed ID: 1953117
[TBL] [Abstract][Full Text] [Related]
20. Neck dissection for unknown cancer of the head and neck in the era of chemoradiation.
Amsbaugh MJ; Yusuf M; Gaskins J; Silverman C; Potts K; Bumpous J; Redman R; Perez C; Dunlap N
Am J Otolaryngol; 2017; 38(5):588-592. PubMed ID: 28633765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
